The transaction represents a significant acquisition in the global digital health sector. Australian headquartered Eucalyptus operates a portfolio of digital healthcare clinics across Australia, the United Kingdom, Europe, Canada and Japan, with consumer brands including Juniper and Pilot. 

The transaction is subject to customary regulatory approvals and is expected to close in mid-2026.   

MinterEllison advised on all legal aspects of the transaction, including cross-border legal due diligence across eight jurisdictions, transaction structuring, negotiation of transaction documentation, FIRB and competition advice, and warranty and indemnity insurance.  

The MinterEllison team was led by Partners Daniel Scotti and Nicole Sloggett, supported by Senior Associate Korey Barbousas, with specialist input across healthcare reg, real estate, intellectual property, litigation, tax, workplace, funds, finance, insurance, FIRB and competition.